Low-dose chemotherapy combined with delayed immunotherapy in the neoadjuvant treatment of non-small cell lung cancer and dynamic monitoring of the drug response in peripheral blood
Chaoyang Liang, Qi Song, Wenhao Zhou, Na Li, Qi Xiong, Chaohu Pan, Shaohong Zhao, Xiang Yan, Xiaoling Zhang, Yaping Long, Juntang Guo, Tao Wang, Weiwei Shi, Shengjie Sun, Bo Yang, , Yi Hu
This study evaluates a modified neoadjuvant chemo-immunotherapy regimen for NSCLC, showing improved response rates and reduced side effects with dynamic monitoring of ctDNA and TCR.
medRxiv · Jul 11, 2024 · PreprintGenetic & Genomic Medicine